Solution — Cessation Programs

Nicotine Pouch Packaging for Stop-Smoking & NRT Programs

Medical-grade, child-resistant packaging for nicotine replacement therapy (NRT) and stop-smoking programs. Private-label and OEM-ready. Compatible with ZYN, Velo, Pablo, and White Fox formats. Compliant with EU TPD Article 20, FDA guidance, and UK MHRA. Program-ready documentation from day one.

What Makes NRT Packaging Different from Recreational Nicotine Pouches?

Stop-smoking programs and nicotine replacement therapy (NRT) channels — NHS clinics, pharmacy chains, employer wellness programs — do not buy packaging the same way recreational brands do. Recreational buyers prioritize shelf appeal and lifestyle branding. NRT buyers prioritize compliance documentation, clinical aesthetics, and batch traceability. While the industry is shifting from traditional snus to modern nicotine pouches, the packaging requirements for stop-smoking programs remain the same — child-resistant, tamper-evident, and fully documented.

Regulatory Scope Is Broader

Recreational nicotine pouches in the EU need TPD Article 20 compliance. NRT programs need TPD Article 20 plus therapeutic-goods alignment — especially in the UK (MHRA) and Australia (TGA). In the US, NRT-adjacent products often fall under FDA Center for Drug Evaluation and Research (CDER) or CPSC guidance, depending on marketing claims. Our regulatory mapping covers all four jurisdictions before design begins.

mg-Strength Labeling Is Non-Negotiable

NRT programs specify exact nicotine strengths — typically 2 mg, 4 mg, 6 mg, 11 mg, or 20 mg per pouch — and the packaging must display this clearly without implying recreational use. We provide label templates that separate "dose" information from brand imagery, ensuring your product reads as a cessation tool at pharmacy checkout. (Internal data: 11 mg formats show 20% higher click-through rates in B2B procurement platforms, suggesting mid-strength SKUs are a sweet spot for program tenders.)

Documentation Must Be Tender-Ready

A recreational order ships with a CR certificate and an invoice. An NRT tender submission requires ISO 8317 test reports, material safety data sheets (MSDS), batch traceability records, REACH declarations, and sometimes FDA 510(k) alignment letters. We pre-format these bundles by market, so your regulatory team spends days — not months — on paperwork.

Compatible with Leading Formats

All formats are compatible with ZYN, Pablo, Velo, White Fox, and Killa. If you are switching from an existing supplier or white-labeling a Velo-compatible stop-smoking format, send us your current spec sheet and we will confirm drop-in compatibility within 24 hours.

Why Cessation Programs Need Specialized Packaging

My tender was rejected because the packaging did not meet NHS requirements

A missing ISO 8317 CR report or an incorrect MHRA registration format can disqualify your entire tender. One oversight costs 6–12 months and tens of thousands in lost revenue — and you may not even know why until the rejection letter arrives.

My current supplier ships cans and leaves me to figure out compliance docs

Most packaging suppliers treat documentation as an afterthought. They deliver the cans and hand you a generic CR certificate. NHS onboarding, FDA 510(k) alignment, and REACH declarations? That is your problem, not theirs.

Explore custom design options

I need to launch in the UK and EU but my supplier only understands US FDA

Single-market suppliers force you to manage multiple vendors for multi-region launches. Each vendor uses different specs, different CR tests, and different batch traceability formats — creating audit gaps at the worst possible time.

Regulatory Compliance by Market

Pre-mapped documentation bundles for the four major cessation-program markets.

Market Standard Requirement Status
🇺🇸 United States FDA / CPSC CR packaging + cessation marketing claims review Fully supported
🇪🇺 European Union TPD Article 20 CR packaging + health warning compliance Requirements mapped
🇬🇧 United Kingdom MHRA / UK TPD Post-Brexit registration + CR compliance Requirements mapped
🇦🇺 Australia TGA Therapeutic goods packaging standards Requirements identified

Not sure which market to enter first? Request a free sample pack →

From Regulatory Map to Market Entry in 5 Steps

Compliance-first packaging for clinics, pharmacies, and government programs.

01

Regulatory Mapping

We identify the exact packaging requirements for your target market — US FDA, EU TPD Article 20, UK MHRA, or AU TGA. No guesswork, no surprises at customs.

02

Design Direction

Choose between medical-grade aesthetics (clinical white, minimal branding) or consumer-grade design (lifestyle colors, bold branding). Both routes are compliance-first.

03

Compliance Documentation

We compile FDA and CPSC-compliant packaging documentation directly. For NHS, MHRA, NIH, and EU cessation programs, we identify the required packaging-level certificates and align our documentation with your regulatory team's specifications.

View compliance documentation
04

Production

Full production with inline QC and batch-level traceability. Every unit is linked to a production lot for audit readiness.

05

Post-Market Support

Packaging-level regulatory updates, re-certification, and audit documentation support for the full program lifecycle. Documentation archived for 7 years.

Required Documentation by Market

What your regulatory team typically needs for tender submission. We compile the packaging-level documents directly; for program-specific registrations, we guide alignment.

🇺🇸US (FDA / CPSC)

  • ISO 8317 CR Report
  • FDA Food-Contact Statement
  • CPSC 16 CFR 1700.20
  • Batch Traceability Template
View US certification details

🇪🇺EU (TPD Art. 20)

  • ISO 8317 CR Report
  • Food-Contact Migration Test
  • REACH SVHC Declaration
  • Batch Traceability Template
  • Health Warning Template
View EU certification details

🇬🇧UK (MHRA)

  • ISO 8317 CR Report
  • UKCA Declaration
  • MHRA Device Registration Guide
  • Batch Traceability Template
  • NHS Onboarding Checklist
View UK certification details

🇦🇺Australia (TGA)

  • ISO 8317 CR Report
  • TGA GMP Alignment Letter
  • Poison Schedule Compliance
  • Batch Traceability Template
View AU certification details

Proof You Can Verify

7 years

Batch documentation archived for regulatory audit traceability

100%

CR certification conformance rate across all shipped batches

10,000 pcs

Minimum pilot order for program trials and tender submissions

Case Study

"A leading EU pharmacy chain launched their NRT program in 6 weeks using our pre-formatted NHS documentation bundle."

From first inquiry to market entry — including ISO 8317 testing, MHRA registration alignment, and batch traceability setup.

See how we helped this client meet NHS requirements

Packaging-Level Documentation Support

FDA and CPSC packaging documentation is pre-formatted. For NHS, NIH, EU, and TGA markets, we identify requirements and align our packaging-level documentation with your regulatory team's specifications. Each alignment includes CR test reports, material safety data sheets, batch traceability templates, and compliance checklists — saving you 6–12 weeks of document preparation. Digital records archived for 7 years. Full traceability reports provided with every shipment.

Explore CR compliance solutions

Frequently asked questions

Do you provide packaging for NHS and government cessation programs?
Yes. We have supplied CR-compliant packaging for NHS-registered nicotine pouch programs in the UK and EU, including NRT-format programs with 2 mg and 4 mg strength labeling. Required documentation typically includes ISO 8317 test reports, material safety data sheets, and batch traceability records — we compile the packaging-level certificates and align them with your regulatory team's tender requirements.
What is the difference between recreational and cessation-program packaging?
Cessation-program packaging typically requires a more clinical aesthetic (muted colors, medical-style labeling), stricter child-resistance documentation, and compliance with therapeutic-goods regulations rather than general consumer-product rules. We offer design templates for both routes.
Can you help with regulatory documentation for program approval?
Yes. Our regulatory team identifies market-specific documentation requirements and compiles what falls within our packaging scope — CR certificates, material compliance statements, and batch traceability records. We have experience aligning packaging documentation with NHS, NIH, and EU cessation program requirements. For program-specific registrations, we guide you through the process.
What MOQ applies to cessation-program orders?
Standard PP plastic cans start at 10,000 units, available in both standard press-fit and CR-certified configurations. For large government tenders (50,000+ units), we offer dedicated production scheduling and enhanced batch documentation. Pilot programs of 10,000–50,000 units are common for initial program trials.
How do you handle batch traceability for medical programs?
Every production batch is assigned a unique lot number linked to raw material certificates, QC test results, and shipping documentation. Digital records are archived for 7 years. Full traceability reports are provided with every shipment.
Can the packaging design be adjusted for different program requirements?
Absolutely. We maintain design templates for both medical-grade (clinical, minimal) and consumer-grade (lifestyle, branded) aesthetics. Label content, health warnings, and CR mechanisms are adjusted per market. One mold can support multiple design variants.
What is NRT, and why does it need different packaging from recreational nicotine pouches?
NRT stands for Nicotine Replacement Therapy — a medical framework for helping people quit smoking using controlled-dose nicotine products. NRT packaging must meet therapeutic-goods standards (not just consumer-product rules), display exact mg-strength per pouch, and include documentation that recreational packaging never needs: ISO 8317 CR reports formatted for NHS, REACH declarations for EU tenders, and batch traceability aligned with FDA 21 CFR. We design for NRT from the first sketch, not as an afterthought.
Can you label packaging with specific mg-strengths like 2 mg, 11 mg, or 20 mg?
Yes. We provide label templates that clearly display nicotine strength per pouch — a requirement for NRT program approval and pharmacy retail. Our templates separate clinical information (dose, usage instructions) from brand imagery to avoid the "lifestyle product" signal that regulators flag. If you are switching from an existing supplier or white-labeling a Velo-compatible format, we can match your current label dimensions and migrate your design to our templates. Compatible with ZYN, Pablo, Velo, White Fox, and Killa formats. Custom label designs are available from 10,000 units with 7-day sampling.
How long does documentation preparation take for a government tender?
For US FDA and CPSC markets, packaging documentation is pre-formatted and ships with your first batch. For EU (TPD Article 20), UK (MHRA), and Australia (TGA), we identify the required certificates and align our packaging-level documentation with your regulatory team's specifications — typically within 2–3 weeks of order confirmation. For new or non-standard markets, our regulatory team maps requirements before production begins.
Do you offer packaging for zero-nicotine or nicotine-free stop-smoking pouches?
Yes. Our PP cans and aluminum cans accommodate both nicotine and zero-nicotine pouch formats. Label templates distinguish nicotine content (2mg–20mg) from nicotine-free variants, ensuring pharmacy buyers can clearly identify the product type. The same child-resistant certification, MOQ of 10,000 units, and 7-day sampling apply to zero-nicotine lines.

Ready for Program Approval?

Request a compliance dossier with regulatory templates, CR certification previews, and a design guide tailored to your target cessation program.

Get Quote Contact Us